WallStreetZenWallStreetZen

NASDAQ: ACON
Aclarion Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ACON

Based on 1 analyst offering 12 month price targets for Aclarion Inc

Min Forecast
$22.00+183.51%
Avg Forecast
$22.00+183.51%
Max Forecast
$22.00+183.51%

Should I buy or sell ACON stock?

Based on 1 analyst offering ratings for Aclarion Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACON stock forecasts and price targets.

ACON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-19

1 of 1

Forecast return on equity

Is ACON forecast to generate an efficient return?

Company
-50.78%
Industry
-0.1%
Market
261.18%
ACON's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACON forecast to generate an efficient return on assets?

Company
-48.84%
Industry
12.48%
ACON is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACON earnings per share forecast

What is ACON's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$14.38
Avg 2 year Forecast
-$12.37

ACON revenue forecast

What is ACON's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$112.2k+78.24%
Avg 2 year Forecast
$275.4k+337.5%
ACON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACON revenue growth forecast

How is ACON forecast to perform vs Health Information Services companies and vs the US market?

Company
78.24%
Industry
11.56%
Market
1,364.9%
ACON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACON vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
ACON$7.76$22.00+183.51%Buy
MNDR$2.60N/AN/A
WORX$0.31N/AN/A
MSPR$0.22N/AN/A
BFRG$1.28N/AN/A
View Top Health Information Service Stocks

Aclarion Stock Forecast FAQ

Is Aclarion Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ACON) stock is to Buy ACON stock.

Out of 1 analyst, 0 (0%) are recommending ACON as a Strong Buy, 1 (100%) are recommending ACON as a Buy, 0 (0%) are recommending ACON as a Hold, 0 (0%) are recommending ACON as a Sell, and 0 (0%) are recommending ACON as a Strong Sell.

If you're new to stock investing, here's how to buy Aclarion stock.

What is ACON's earnings growth forecast for 2025-2026?

(NASDAQ: ACON) Aclarion's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 134.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,855.71%.

Aclarion's earnings in 2025 is -$7,060,299.On average, 3 Wall Street analysts forecast ACON's earnings for 2025 to be -$8,375,660, with the lowest ACON earnings forecast at -$8,047,202, and the highest ACON earnings forecast at -$8,622,003.

In 2026, ACON is forecast to generate -$7,205,443 in earnings, with the lowest earnings forecast at -$6,922,877 and the highest earnings forecast at -$7,417,368.

What is ACON's revenue growth forecast for 2025-2026?

(NASDAQ: ACON) Aclarion's forecast annual revenue growth rate of 78.24% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 11.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,364.9%.

Aclarion's revenue in 2025 is $62,949.On average, 3 Wall Street analysts forecast ACON's revenue for 2025 to be $65,342, with the lowest ACON revenue forecast at $62,780, and the highest ACON revenue forecast at $67,264.

In 2026, ACON is forecast to generate $160,385 in revenue, with the lowest revenue forecast at $154,095 and the highest revenue forecast at $165,102.

What is ACON's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ACON) forecast ROA is -48.84%, which is lower than the forecast US Health Information Services industry average of 12.48%.

What is ACON's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ACON price target, the average ACON price target is $22.00, with the highest ACON stock price forecast at $22.00 and the lowest ACON stock price forecast at $22.00.

The Wall Street analyst predicted that Aclarion's share price could reach $22.00 by Sep 19, 2026. The average Aclarion stock price prediction forecasts a potential upside of 183.51% from the current ACON share price of $7.76.

What is ACON's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ACON) Aclarion's current Earnings Per Share (EPS) is -$2,969.57. On average, analysts forecast that ACON's EPS will be -$14.38 for 2025, with the lowest EPS forecast at -$13.82, and the highest EPS forecast at -$14.81. In 2026, ACON's EPS is forecast to hit -$12.37 (min: -$11.89, max: -$12.74).

What is ACON's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ACON) forecast ROE is -50.78%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.